Pharmsville Co., Ltd. (KOSDAQ:318010)
South Korea · Delayed Price · Currency is KRW 3,575.00
+10.00 (0.28%)
At close: May 29, 2026
Pharmsville Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,989 | 2,889 | 1,583 | 3,310 | 4,063 | 5,000 |
Depreciation & Amortization | 595.99 | 640.74 | 674.9 | 675.99 | 671.39 | 216.32 |
Loss (Gain) From Sale of Assets | - | - | - | 33.82 | -41.82 | - |
Asset Writedown & Restructuring Costs | - | - | 118 | - | - | - |
Loss (Gain) From Sale of Investments | -3,114 | -2,810 | -533.33 | -403.42 | 426.57 | 778.66 |
Loss (Gain) on Equity Investments | - | - | - | 63.31 | 32.09 | 24.6 |
Provision & Write-off of Bad Debts | 2.76 | 4.38 | -28.1 | 3.29 | - | 27.62 |
Other Operating Activities | 1,043 | 1,000 | -43.8 | 86.72 | -1,284 | 1,282 |
Change in Accounts Receivable | 278.78 | 240.47 | 166.41 | 770.44 | 486.7 | -523.8 |
Change in Inventory | 737.87 | 949.03 | 553.31 | -243.46 | 1,837 | 847.71 |
Change in Accounts Payable | -326.79 | -38.29 | -568.65 | 106.96 | -837.7 | -316.47 |
Change in Other Net Operating Assets | -686.26 | -981.07 | -2,268 | 248.13 | -149.61 | 936.23 |
Operating Cash Flow | 1,520 | 1,894 | -346.56 | 4,651 | 5,203 | 8,273 |
Operating Cash Flow Growth | - | - | - | -10.61% | -37.10% | 11946.19% |
Capital Expenditures | -2.86 | -2.86 | -26.18 | -201.48 | -119.79 | -291.03 |
Sale of Property, Plant & Equipment | 168.61 | 168.61 | - | - | 41.82 | - |
Sale (Purchase) of Intangibles | -74.22 | -67.65 | -78.94 | 1.44 | -24.36 | -34.1 |
Investment in Securities | 1,906 | -18,326 | 15,721 | -9,479 | 622.59 | -2,304 |
Other Investing Activities | 4.69 | 3.19 | -4.77 | 7.04 | 1 | 29 |
Investing Cash Flow | 3,002 | -17,224 | 15,611 | -10,672 | 521.26 | -2,600 |
Long-Term Debt Issued | - | - | - | - | 2,377 | 50 |
Long-Term Debt Repaid | - | -7.12 | -2,190 | -5,099 | -3,112 | -480.34 |
Net Debt Issued (Repaid) | -6.79 | -7.12 | -2,190 | -5,099 | -734.85 | -430.34 |
Repurchase of Common Stock | - | - | - | -824.54 | - | - |
Dividends Paid | -772.81 | -772.81 | -774.99 | -784.64 | -784.64 | -784.64 |
Other Financing Activities | -2 | -2 | 4.5 | -7.5 | - | - |
Financing Cash Flow | -781.6 | -781.93 | -2,960 | -6,716 | -1,519 | -1,215 |
Foreign Exchange Rate Adjustments | 0.87 | -16.28 | 27.74 | -3.89 | -26.54 | 15.67 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | -0 | -0 | - |
Net Cash Flow | 3,742 | -16,129 | 12,332 | -12,740 | 4,179 | 4,474 |
Free Cash Flow | 1,517 | 1,891 | -372.74 | 4,450 | 5,083 | 7,982 |
Free Cash Flow Growth | - | - | - | -12.46% | -36.31% | - |
Free Cash Flow Margin | 12.77% | 14.86% | -2.23% | 20.80% | 19.47% | 20.45% |
Free Cash Flow Per Share | 196.32 | 244.68 | -48.27 | 568.20 | 647.87 | 1017.25 |
Cash Interest Paid | 0.83 | 0.89 | 47.83 | 156.35 | 149.21 | 70.62 |
Cash Income Tax Paid | - | -381.17 | 484.42 | 949.59 | 1,718 | 333.14 |
Levered Free Cash Flow | -74.3 | 1,068 | -207.97 | 2,264 | 3,680 | 5,535 |
Unlevered Free Cash Flow | -73.78 | 1,068 | -180.3 | 2,358 | 3,775 | 5,581 |
Change in Working Capital | 3.61 | 170.14 | -2,117 | 882.08 | 1,336 | 943.68 |